A comprehensive view of BioNTech SE. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "RNA CONSTRUCTS AND USES THEREOF"
Published:
April 17, 2024
by U.S. Fed News
|
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published:
April 15, 2024
by FiercePharma
|
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "RNA COMPOSITIONS TARGETING CLAUDIN-18.2"
Published:
April 14, 2024
by U.S. Fed News
|
Biontech SE Applies for Patent on Preparation and Storage of Liposomal Rna Formulations Suitable for Therapy
Published:
April 13, 2024
by Medical Patent News
|
US Patent Issued to BioNTech on April 9 for "RNA constructs and uses thereof" (German, American Inventors)
Published:
April 10, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view